Effect of extended-spectrum β-lactamases on the susceptibility of Haemophilus influenzae to cephalosporins

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 1, 2003, Pages 39-43

  Tristram, Stephen G ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Extended spectrum lactamase; TEM lactamase

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAMASE; CEFACLOR; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE;

ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DIFFUSION; ENZYME ANALYSIS; ENZYME SYNTHESIS; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; WILD TYPE;

BETA-LACTAMASES; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; HAEMOPHILUS INFLUENZAE; MICROBIAL SENSITIVITY TESTS;

EID: 0037259532     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg015     Document Type: Article

References (33)

1. Sutcliffe, J. G. (1978). Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proceedings of the National Academy of Sciences, USA 75, 3737-41.
2. Goussard, S. & Courvalin, P. (1991). Sequences of the genes blaT-1B and blaT-2. Gene 102, 71-3.
3. Levesque, R. C. & Jacoby, G. A. (1988). Molecular structure and interrelationships of multiresistance β-lactamase transposons. Plasmid 19, 21-9.
4. Laufs, R., Riess, F., Jahn, G., Fock, R. & Kaulfers, P. (1981). Origin of Haemophilus influenzae R factors. Journal of Bacteriology 147, 563-8.
5. Doern, G. V. & The Alexander Project Collaborative Group (1996). Antimicrobial resistance among lower respiratory tract isolates of Haemophilus influenzae: results of a 1992-93 Western Europe and USA collaborative surveillance study. Journal of Antimicrobial Chemotherapy 38, Suppl. A, 59-69.
6. Jorgensen, J. H. (1992). Update on mechanisms and prevalence of antimicrobial resistance in Haemophilus influenzae. Clinical Infectious Diseases 14, 1119-23.
7. Powell, M. (1991). Chemotherapy for infections caused by Haemophilus influenzae: current problems and future prospects. Journal of Antimicrobial Chemotherapy 27, 3-7.
8. Mendelman, P. M., Chaffin, D. O. & Kalaitzoglou, G. (1990). Penicillin-binding proteins and ampicillin resistance in Haemophilus influenzae. Journal of Antimicrobial Chemotherapy 25, 525-34.
9. James, P. A., Lewis, D. A., Jordens, J. Z., Cribb, J., Dawson, S. J. & Murray, S. A. (1996). The incidence and epidemiology of beta-lactam resistance in Haemophilus influenzae. Journal of Antimicrobial Chemotherapy 37, 737-46.
10. Jacoby, G. A. (1994). Genetics of extended spectrum β-lactamases. European Journal of Clinical Microbiology and Infectious Diseases 13, Suppl. 1, 2-11.
11. Jacoby, G. A. & Medeiros, A. (1991). More extended spectrum β-lactamases. Antimicrobial Agents and Chemotherapy 35, 1697-704.
12. Dimopoulou, I. D., Kraak, W. A., Anderson, E. C., Nichols, W. W., Slack, M. P. & Crook, D. W. (1992). Molecular epidemiology of unrelated clusters of multiresistant strains of Haemophilus influenzae. Journal of Infectious Diseases 165, 1069-75.
13. Tristram, S. G. (1999). Extended spectrum β-lactamases in Haemophilus? Australian Journal of Medical Science 20, 33-41.
14. Philippon, A., Redjeb, S. B., Fournier, G. & Hassen, A. B. (1989). New plasmid borne β-lactamases. Infection 17, 347-54.
15. Doern, G. V. & Jones, R. N. (1993). In vitro susceptibility test practices with Haemophilus influenzae among College of American Pathologists survey participants in the United States. Diagnostic Microbiology and Infectious Disease 17, 61-5.
16. Jones, R. N., Thornsberry, C., Hindler, J., Gerlach, E. H. & Doern, G. V. (1992). The re-evaluation of the NCCLS ampicillin susceptibility tests with Haemophilus test medium: new interpretive criteria for the disk diffusion method. Antimicrobial Newsletter 8, 31-5.
17. Sougakoff, W., Goussard, S., Gerbaud, G. & Courvalin, P. (1988). Plasmid mediated resistance to third generation cephalosporins caused by point mutations in TEM-type penicillinase genes. Reviews of Infectious Diseases 10, 879-84.
18. Sougakoff, W., Petit, A., Goussard, S., Sirot, D., Bure, A. & Courvalin, P. (1989). Characterization of the plasmid genes blaT-4 and blaT-5 which encode the broad spectrum β-lactamases TEM-4 and TEM-5 in Enterobacteriaceae. Gene 78, 339-48.
19. Willson, P. J., Albritton, W. L., Slaney, L. & Setlow, J. K. (1989). Characterization of a multiple antibiotic resistance plasmid from Haemophilus ducreyi. Antimicrobial Agents and Chemotherapy 33, 1627-30.
20. Balko, T., Karlowsky, J. A., Palatnick, L. P., Zhanel, G. G. & Hoban, D. J. (1999). Characterization of the inoculum effect with Haemophilus influenzae and β-lactams. Diagnostic Microbiology and Infectious Disease 33, 47-58.
21. Barcak, G. J., Chandler, M. S., Redfield, R. J. & Tomb, J. (1991). Genetic systems in Haemophilus influenzae. Methods in Enzymology 204, 321-42.
22. Brun-Buisson, C., Legrand, P., Philipon, A., Montravers, F., Ansquer, M. & Duval, J. (1987). Tranferable enzymatic resistance to third generation cephalosporins during a nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet ii, 302-6.
23. Chanal, C., Poupart, M., Sirot, D., Labia, R., Sirot, J. & Cluzel, R. (1992). Nucleotide sequences of CAZ-2, CAZ-6, and CAZ-7 β-lactamase genes. Antimicrobial Agents and Chemotherapy 36, 1817-20.
24. National Committee for Clinical Laboratory Standards. (2000). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fifth Edition: Approved Standard M7-A5. NCCLS, Villanova, PA, USA.
25. National Committee for Clinical Laboratory Standards. (2000). Performance Standards for Antimicrobial Disk Susceptibility Tests - Sixth Edition: Approved Standard M2-A7. NCCLS, Villanova, PA, USA.
26. James, P. A. & Reeves, D. S. (1996). Bacterial resistance to cephalosporins as a function of outer membrane permeability and access to their target. Journal of Chemotherapy 8, Suppl. 2, 37-47.
27. Wu, P., Shannon, K. & Phillips, I. (1995). Mechanisms of hyperproduction of TEM-1 β-lactamase by clinical isolates of Escherichia coli. Journal of Antimicrobial Chemotherapy 36, 927-39.
28. Jacoby, G. & Bush, K. (2002). Amino acid sequences for TEM, SHV and OXA extended-spectrum and inhibitor resistant β-lactamases. [Online.] http://www.lahey.org/studies/webt.stm (10 July 2002, date last accessed).
29. Bonnet, R., De Champs, C., Sirot, D., Chanal, C., Labia, R. & Sirot, J. (1999). Diversity of TEM mutants in Proteus mirabilis. Antimicrobial Agents and Chemotherapy 43, 2671-7.
30. Medeiros, A. A. & O'Brien, T. F. (1975). Ampicillin-resistant Haemophiluis influenzae type B possessing a TEM-type β-lactamase but little permeability barrier to ampicillin. Lancet i, 716-8.
31. Verbist, L. (1993). Relevance of antibiotic susceptibility testing for clinical practice. European Journal of Clinical Microbiology and Infectious Diseases 12, Suppl. 1, 2-5.
32. James, P. A., Hossain, F. K., Lewis, D. A. & White, D. G. (1993). β-Lactam susceptibility of Haemophilus influenzae strains showing reduced susceptibility to cefuroxime. Journal of Antimicrobial Chemotherapy 32, 239-46.
33. Dagan, R., Abramson, O., Leibovitz, E., Greenberg, D., Lang, R., Goshen, S. et al. (1997). Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media? Journal of Infectious Diseases 178, 1253-9.